- Ticker
- ABIO
- Price
- 2.05
- Stock movement down
- -0.06 (-2.84%)
- Company name
- ARCA Biopharma Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 29.54M
- Ent value
- -12.16M
- Price/Sales
- -
- Price/Book
- 0.69
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -13.87%
- 3 year return
- -7.62%
- 5 year return
- -28.70%
- 10 year return
- -40.13%
Last updated: 2023-03-22
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
October 28, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
August 2, 2022
iO Charts is a Seeking Alpha partner
DIVIDENDS
ABIO does not pay dividends or no data was received
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
August 2, 2022
iO Charts is a Seeking Alpha partner
Activist is pushing ARCA biopharma to stop new developments and return cash to shareholders. Click here to learn more about ABIO stock.
May 3, 2022
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.69 |
| EV to Sales | - |
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
May 2, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
April 18, 2022
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 14.41M |
| EPS (TTM) | -1.00 |
| FCF per share (TTM) | -1.00 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -14.73M |
| Net income (TTM) | -14.43M |
| EPS (TTM) | -1.00 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 43.94M |
| Net receivables | 0.00 |
| Total current assets | 44.55M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 44.97M |
| Accounts payable | 593.00K |
| Short/Current long term debt | 301.00K |
| Total current liabilities | 1.94M |
| Total liabilities | 2.24M |
| Shareholder's equity | 42.73M |
| Net tangible assets | 42.73M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -14.37M |
| Capital expenditures (TTM) | 9.00K |
| Free cash flow (TTM) | -14.37M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -33.77% |
| Return on Assets | -32.09% |
| Return on Invested Capital | -33.77% |
| Cash Return on Invested Capital | -33.64% |
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
March 31, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
March 14, 2022
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.10 |
| Daily high | 2.10 |
| Daily low | 2.05 |
| Daily Volume | 15K |
| All-time high | 5726700.00 |
| 1y analyst estimate | 7.00 |
| Beta | 1.64 |
| EPS (TTM) | -1.00 |
| Dividend per share | - |
| Ex-div date | 1 May 2006 |
| Next earnings date | 1 May 2023 |
Downside potential
Loading...
Downside potential data
| ABIO | S&P500 | |
| Current price drop from All-time high | -100.00% | -17.92% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 22 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -93.88% | -11.51% |
| Avg time to new high | 280 days | 13 days |
| Max time to new high | 5809 days | 1805 days |
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
December 2, 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
November 2, 2021
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
29.54M
Marketcap category
Small-cap
Description
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.
Employees
17
Website
Investor relations
-
SEC filings
CEO
Michael R. Bristow
Country
USA
City
Westminster
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
October 28, 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
September 16, 2021
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
The following slide deck was published by ARCA biopharma, Inc.
August 23, 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
August 9, 2021
iO Charts is a Seeking Alpha partner
COMPANY NEWS
All newsPress releases
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic optionsWESTMINSTER, Colo., Feb. 24, 2023 (GLOBE NEWSWIRE...
February 24, 2023
We can readily understand why investors are attracted to unprofitable companies. For example, although...
February 3, 2023
WESTMINSTER, Colo., Dec. 19, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that James Flynn has joined its Board of Directors. “We are pleased to welcome James Flynn to ...
December 19, 2022
Viewing insider transactions for ARCA biopharma, Inc.'s ( NASDAQ:ABIO ) over the last year, we see that insiders were...
November 14, 2022
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic optionsWESTMINSTER, Colo., Oct. 28, 2022 (GLOBE NEWSWIRE...
October 28, 2022
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., Aug. 02, 2022 (GLOBE NEWSWIR...
August 2, 2022
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
July 18, 2022
WESTMINSTER, Colo., June 21, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that Jacob Ma-Weaver has joined its Board of Directors. “We are pleased to welcome Jacob Ma-We...
June 21, 2022
WESTMINSTER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that it has retained Ladenburg Thalmann & Co. Inc. to act as its financial advisor. In April 20...
May 5, 2022
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., May 02, 2022 (GLOBE NEWSWIRE...
May 2, 2022
Next page
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
August 4, 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
July 13, 2021
iO Charts is a Seeking Alpha partner